News Daily News Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed L.A. McKeown December 01, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017